Design, Expression, and Binding Interactions Study of the Recombinant Engineered IL-6R
This engineered protein has potential for further investigation as a promising and cost-effective therapeutic agent targeting IL-6-related pathologies.
Authors
- Maryam Tabarzad (ORCID: https://orcid.org/0000-0001-9923-0639)
- Sepideh Ghani (ORCID: https://orcid.org/0000-0003-2691-0523)
- Bahram Kazemi (ORCID: https://orcid.org/0000-0001-8448-3406)
- Mojgan Bandehpour
- Adel Haghighi
- Mahya Nasrollahi (ORCID: https://orcid.org/0009-0001-5992-676X)
- Elham Mehdizadeh Marzenaki
Institutions
- Islamic Azad University, Science and Research Branch (IR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Iranian journal of pharmaceutical research
- Published
- 2025-11-16
- DOI
- https://doi.org/10.5812/ijpr-165026
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shahid Beheshti University of Medical Sciences